Hamilton Ridge Hospital stunned clinicians across Canada this month after an emergency programme using inhaled bacteriophage cocktails — naturally occurring viruses that attack bacteria — produced rapid bacterial clearance in 87% of treated patients with ventilator‑associated, multi‑drug resistant pneumonia. The hospital says 32 of the 46 patients treated since March were taken off mechanical ventilation within two weeks, a recovery pace clinicians described as unprecedented for this population.
The intervention began in March as a last‑resort, compassionate‑use pathway arranged by a small local team led by researcher Melissa S. Hang at the Great Lakes Infectious Disease Consortium. Phage therapy is experimental in Canada and tightly regulated overseas; the Canada Health Agency granted an emergency authorisation in June after clinicians reported single‑patient successes. “We started with utter scepticism,” said Hang, director of microbial therapeutics at the consortium. “By early September we realised this was not a trick of luck — the bacteria were being eliminated in hours, not weeks.”
Treating ventilated patients is costly and risky: prolonged intubation commonly leads to bacteria that resist carbapenems and other last‑line antibiotics. Hamilton Ridge treated 46 such patients between March and 15 September with personalised nebulised phage cocktails developed from bacterial samples taken from each patient. Lab analysis and serial bronchoscopies showed bacterial loads plummeting by an average of 98% within 72 hours, the team reports in an internal brief seen by this paper.
The human stories have been striking. Suraj Issac, 53, a warehouse worker from Burlington, was told in late July that his odds of surviving a superbug lung infection were slim and to call his family. Three days after the phage treatment he began breathing on his own. “I remember feeling the weight lift off my chest — literally,” Issac said in hospital this week, his voice fragile but elated. “They told me it was a virus that kills bacteria. It sounded crazy. It worked.”
Nurses and intensivists at Hamilton Ridge said they had never seen such consistent turnarounds. “I’ve been in critical care for 18 years,” said Anne‑Marie Graversen, an intensive‑care charge nurse. “We go into these cases expecting slow, incremental gains. Here we were extubating people who had been septic for weeks. The speed was astonishing and emotional — families were crying in the hall.”
The results have prompted immediate regulatory, manufacturing and ethical questions. Théophile Paul, director of emergency authorisations at the Canada Health Agency, told The Plausible Post the agency had opened a rapid review of the Hamilton programme and was working with provincial health ministries to expand access if independent audits confirm the findings. “We must be rigorous,” Paul said. “But these outcomes, if reproducible, could change the way we treat drug‑resistant respiratory infections in intensive care.”
Scaling is the immediate bottleneck. Personalized phage cocktails require isolating the patient’s bacterial strain, matching phages, and producing sterile formulations — a process that currently takes days to weeks in specialist labs. Melissa Hang said her team was negotiating with two Canadian biologics firms to set up regional phage banks and streamline matching pipelines, but she warned against premature optimism: “Phages are living therapies; they mutate, they interact. There are efficacy and safety steps that must not be skipped.”
Families affected want speed. Kalyani P. Sekhon, whose 67‑year‑old mother spent 24 days ventilated before receiving phage therapy in August, said the programme bought them time and hope. “I don’t know who thought a virus would save my mother, but I saw her come back,” Sekhon said. “If regulators can help other hospitals get the same tools, they should move fast — but safely.” Provincial health officials in Ontario and two other provinces said they were preparing to fund multi‑centre trials starting this autumn; hospitals in British Columbia and Quebec have already asked for shipment of phage samples for pilot testing.
